|
|
|
|
|
|
|
|
|
Perrigo reports record revenue again
The company will transfer some API production from Israel to a newly purchased company in India.
Globes[online] (18 Aug 2009)
Perrigo Company (Nasdaq:PRGO; TASE:PRGO) today published its financial report for its fourth fiscal quarter and full fiscal year of 2009, which ended in June. The US-Israeli generic drugs company reported record revenue for the third consecutive year.
Perrigo posted $508.2 million revenue the fourth fiscal quarter of 2009, 7% more than the $474.3 million revenue for the corresponding quarter of 2008. GAAP-based net profit was flat at $32.3 million ($0.35 per share) for the fourth fiscal quarter, compared with $32.2 million for the corresponding quarter. Non-GAAP net profit rose to $46.9 million ($0.50 per share) from $42.1 million. The company beat the analysts' consensus of $0.46 per share.
|
|
|
| ©2010 The Trendlines Group Ltd. All rights reserved. This site contains material copyrighted by third parties.
|
|
|